Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Liabilities: 2024

Historic Total Liabilities for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $346.5 million.

  • Kura Oncology's Total Liabilities rose 638.82% to $406.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.8 million, marking a year-over-year increase of 638.82%. This contributed to the annual value of $346.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Total Liabilities of $346.5 million as of FY2024.
  • In the past 5 years, Kura Oncology's Total Liabilities registered a high of $346.5 million during FY2024, and its lowest value of $346.5 million during FY2024.
  • For the 1-year period, Kura Oncology's Total Liabilities averaged around $346.5 million, with its median value being $346.5 million (2024).